Nome |
# |
Balò’s concentric sclerosis : still to be considered as a variant of multiple sclerosis?, file dfa8b995-c0e1-748b-e053-3a05fe0a3a96
|
399
|
The novel GRN g.1159-1160delTG mutation is associated with behavioral variant frontotemporal dementia, file dfa8b993-ce70-748b-e053-3a05fe0a3a96
|
345
|
Alemtuzumab in multiple sclerosis during the COVID-19 pandemic: A mild uncomplicated infection despite intense immunosuppression, file dfa8b9a2-2a96-748b-e053-3a05fe0a3a96
|
226
|
Age at symptom onset and death and disease duration in genetic frontotemporal dementia : an international retrospective cohort study, file dfa8b9a2-46db-748b-e053-3a05fe0a3a96
|
174
|
Profiling of ubiquitination pathway genes in peripheral cells from patients with frontotemporal dementia due to C9ORF72 and GRN mutations, file dfa8b995-d2b1-748b-e053-3a05fe0a3a96
|
165
|
Uncovering the heterogeneity and temporal complexity of neurodegenerative diseases with Subtype and Stage Inference, file dfa8b99d-b23f-748b-e053-3a05fe0a3a96
|
162
|
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study, file dfa8b99a-3293-748b-e053-3a05fe0a3a96
|
160
|
Parieto-occipital sulcus widening differentiates posterior cortical atrophy from typical Alzheimer disease, file dfa8b9a5-c837-748b-e053-3a05fe0a3a96
|
159
|
The brain is hypothermic in patients with mitochondrial diseases, file dfa8b995-9cac-748b-e053-3a05fe0a3a96
|
147
|
Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study, file dfa8b99d-05eb-748b-e053-3a05fe0a3a96
|
138
|
Distinct patterns of brain atrophy in Genetic Frontotemporal Dementia Initiative (GENFI) cohort revealed by visual rating scales, file dfa8b99c-f171-748b-e053-3a05fe0a3a96
|
137
|
Usefulness of multi-parametric MRI for the investigation of posterior cortical atrophy, file dfa8b995-7a8a-748b-e053-3a05fe0a3a96
|
135
|
Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: From biological biomarkers to clinical syndromes, file dfa8b9a0-0e21-748b-e053-3a05fe0a3a96
|
116
|
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients, file dfa8b9a6-022a-748b-e053-3a05fe0a3a96
|
107
|
Behavioral and Neurophysiological Effects of Transcranial Direct Current Stimulation (tDCS) in Fronto-Temporal Dementia, file dfa8b99d-b8fa-748b-e053-3a05fe0a3a96
|
103
|
Social cognition impairment in genetic frontotemporal dementia within the GENFI cohort, file dfa8b9a4-bb7f-748b-e053-3a05fe0a3a96
|
102
|
Diogenes syndrome in dementia: a case report, file dfa8b9a6-8133-748b-e053-3a05fe0a3a96
|
92
|
Cerebrospinal fluid glutamate changes in functional movement disorders, file dfa8b9a5-1b35-748b-e053-3a05fe0a3a96
|
70
|
Clinical features and disease course of patients with acute ischaemic stroke just before the Italian index case: Was COVID-19 already there?, file dfa8b9a5-f228-748b-e053-3a05fe0a3a96
|
70
|
CSF β-amyloid predicts prognosis in patients with multiple sclerosis, file dfa8b9a0-432d-748b-e053-3a05fe0a3a96
|
68
|
Facing the digital divide into a dementia clinic during COVID-19 pandemic: caregiver age matters, file dfa8b9a8-684d-748b-e053-3a05fe0a3a96
|
45
|
Biomarkers and phenotypic expression in Alzheimer’s disease: exploring the contribution of frailty in the Alzheimer’s Disease Neuroimaging Initiative, file dfa8b9a9-93f3-748b-e053-3a05fe0a3a96
|
33
|
The Role of Glymphatic System in Alzheimer’s and Parkinson’s Disease Pathogenesis, file 6ebc0c81-eb2b-4c20-abe8-3cea2243d706
|
18
|
White Matter Hyperintensities Are No Major Confounder for Alzheimer's Disease Cerebrospinal Fluid Biomarkers, file dfa8b9a9-8edd-748b-e053-3a05fe0a3a96
|
15
|
A Novel Automated Chemiluminescence Method for Detecting Cerebrospinal Fluid Amyloid-Beta 1-42 and 1-40, Total Tau and Phosphorylated-Tau: Implications for Improving Diagnostic Performance in Alzheimer’s Disease, file 7b588792-189b-482b-8020-b626f382e430
|
14
|
Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation, file 08f7911d-5ded-4af4-aa8a-51f8ee808822
|
12
|
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia, file 69d44fe9-21d8-4961-bd48-ebedc3fc5cac
|
10
|
CSF β-amyloid as a putative biomarker of disease progression in multiple sclerosis, file dfa8b999-daaf-748b-e053-3a05fe0a3a96
|
9
|
Circulating Non-Coding RNA Levels Are Altered in Autosomal Dominant Frontotemporal Dementia, file 4d576608-f320-4545-8eb1-77ed7b5d0c2e
|
8
|
Plasma microglial-derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect, file 53ff7a0a-3a57-4ae9-9b9c-038f970d1a7b
|
8
|
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer's Disease Patients and Controls after Correction for Ventricular Volumes, file dfa8b999-79da-748b-e053-3a05fe0a3a96
|
7
|
Association between enlarged perivascular spaces and cerebrospinal fluid aquaporin-4 and tau levels: report from a memory clinic, file 19a8393c-4ee1-40ff-ad3b-fb23aaa1d6cd
|
5
|
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion : late-onset psychotic clinical presentation, file dfa8b997-148d-748b-e053-3a05fe0a3a96
|
5
|
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes, file dfa8b99e-165b-748b-e053-3a05fe0a3a96
|
5
|
Inflammatory molecules in Frontotemporal Dementia : Cerebrospinal fluid signature of progranulin mutation carriers, file dfa8b993-a368-748b-e053-3a05fe0a3a96
|
4
|
Evidence of CNS β-amyloid deposition in Nasu-Hakola disease due to the TREM2 Q33X mutation, file dfa8b999-d74f-748b-e053-3a05fe0a3a96
|
4
|
CSF β-amyloid predicts prognosis in patients with multiple sclerosis, file dfa8b99f-103a-748b-e053-3a05fe0a3a96
|
4
|
Structural and metabolic cerebral alterations between elderly bipolar disorder and behavioural variant frontotemporal dementia: A combined MRI-PET study, file dfa8b99e-e196-748b-e053-3a05fe0a3a96
|
3
|
Cerebral perfusion changes in presymptomatic genetic frontotemporal dementia: A GENFI study, file dfa8b99f-043c-748b-e053-3a05fe0a3a96
|
3
|
Partial recovery after severe immune reconstitution inflammatory syndrome in a multiple sclerosis patient with progressive multifocal leukoencephalopathy, file dfa8b996-0f6a-748b-e053-3a05fe0a3a96
|
2
|
Plasma Screening for Progranulin Mutations in Patients with Progressive Supranuclear Palsy and Corticobasal Syndromes, file dfa8b998-b0b6-748b-e053-3a05fe0a3a96
|
2
|
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia, file dfa8b99d-4ee1-748b-e053-3a05fe0a3a96
|
2
|
Inflammatory expression profile in peripheral blood mononuclear cells from patients with Nasu-Hakola Disease, file dfa8b99e-18dc-748b-e053-3a05fe0a3a96
|
2
|
Functional network resilience to pathology in presymptomatic genetic frontotemporal dementia, file dfa8b99f-0438-748b-e053-3a05fe0a3a96
|
2
|
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis : a longitudinal OCT study, file dfa8b9a2-9183-748b-e053-3a05fe0a3a96
|
2
|
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome, file dfa8b9a9-c4f7-748b-e053-3a05fe0a3a96
|
2
|
Teaching Neuroimage: Crowned Dens Syndrome, an Acute Attack of Calcium Pyrophosphate Deposition Disease Mimicking Acute Meningitis, file 272fc8f5-f463-4a07-8c93-e872ed39cf97
|
1
|
Altered Extracellular Vesicle miRNA Profile in Prodromal Alzheimer's Disease, file aee09415-9ffb-48d4-b715-ca6eba8f2cf1
|
1
|
Unravelling the Association Between Amyloid-PET and Cerebrospinal Fluid Biomarkers in the Alzheimer's Disease Spectrum: Who Really Deserves an A+?, file d5e0c339-f028-4532-bbaf-b965db94d06c
|
1
|
PINK1 parkinsonism and Parkinson disease : distinguishable brain mitochondrial function and metabolomics, file dfa8b991-a473-748b-e053-3a05fe0a3a96
|
1
|
A 66-year-old patient with vanishing white matter disease due to the p.Ala87Val EIF2B3 mutation, file dfa8b994-27cb-748b-e053-3a05fe0a3a96
|
1
|
A novel MAPT mutation associated with the clinical phenotype of progressive nonfluent aphasia, file dfa8b99c-77c4-748b-e053-3a05fe0a3a96
|
1
|
Profiling of specific gene expression pathways in peripheral cells from prodromal Alzheimer's disease patients, file dfa8b99d-4c46-748b-e053-3a05fe0a3a96
|
1
|
Monozygotic Twins with Frontotemporal Dementia Due to Thr272fs GRN Mutation Discordant for Age at Onset, file dfa8b99d-e0ef-748b-e053-3a05fe0a3a96
|
1
|
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis], file dfa8b9a5-b061-748b-e053-3a05fe0a3a96
|
1
|
Niemann-Pick Type C 1 (NPC1) and NPC2 gene variability in demented patients with evidence of brain amyloid deposition, file dfa8b9a9-d9ff-748b-e053-3a05fe0a3a96
|
1
|
Evidence of retinal anterograde neurodegeneration in the very early stages of multiple sclerosis: a longitudinal OCT study, file e893ee03-95a9-46b0-86bf-d6b345ea1b3c
|
1
|
Banks of the Superior Temporal Sulcus in Alzheimer's Disease: A Pilot Quantitative Susceptibility Mapping Study, file ee19f325-5a2f-4c15-b89e-0c0a80cee430
|
1
|
Totale |
3.313 |